Court Blocks Mifepristone Mail Delivery, Access at Risk

0:00On May 2nd, a federal appeals court just dropped a major ruling blocking the male delivery of myfep Pristone, the most common abortion pill in the U.S. This unanimous decision from a three-judge panel in New Orleans means prescriptions now require in-person pickups at clinics overriding FDA rules that allow telehealth and shipping. The court sided with Louisiana, saying male pills undermine the state's total abortion ban by letting abortions happen remotely. This reverses changes the FDA made during COVID when they dropped in-person requirements after years of safety data showed it was fine without direct supervision reactions are split hard abortion rights groups warn it'll hit rural folks low-income patients and those with disabilities the worst cutting access to early abortions and even miscarriage-cared nationwide not just in band states anti-abortion advocates call it a win for safety and oversight. If at Pristone, approved back in 2000, pairs with another drug for early pregnancies and

1:02powers most U.S. abortions. Courts rarely override FDA science like this, especially since judges usually defer to their expertise on drug regs. This sets up a fast track to the Supreme Court where both sides are gearing up for battle after their recent sidestep on the issue. Keep an eye on how this ripples out as access hangs in the balance. From around the world powered by AI, this is Global News Today, I'm Corey with The Story.